Overview

* Vitalhub ( VHIBF ) Q3 revenue up 94% yr/yr, beating analyst expectations

* Adjusted EBITDA increased 58% yr/yr, representing 22% of revenue

* Company focuses on integrating acquisitions and enhancing margins

Result Drivers

* ACQUISITION GROWTH - ARR increase driven by acquisitions, contributing C$12 mln in Q3

* PROJECT DELIVERIES - Completed project deliveries exceeded expectations, boosting services revenue

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat C$32 mln C$28.40

Revenue mln (9

Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

* Wall Street's median 12-month price target for Vitalhub Corp ( VHIBF ) is C$15.00, about 31.9% above its November 5 closing price of C$10.22

* The stock recently traded at 39 times the next 12-month earnings vs. a P/E of 59 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)